FDA Inspection
CSL Plasma, Inc.CSL Plasma, Inc. – FDA Inspection, Aug 30, 2013
Record Details
This FDA Inspection record concerns CSL Plasma, Inc., with an inspection on August 30, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- CSL Plasma, Inc.
- Inspection Date
- August 30, 2013
- Product Type
- Biologics
View Company Profile
ID · 7800278e-31c6-44a9-9ab8-4349ab543262
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 847834
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CSL Plasma, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 3, 2021 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| December 5, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 30, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 1, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for CSL Plasma, Inc.
- FDA Inspection 1156809 - 2021-11-03
- FDA Inspection 993319 - 2016-12-05
- FDA Inspection 902605 - 2014-10-30
- FDA Inspection 701178 - 2010-12-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.